Dossier · PEB · Dormant
PEB · Pebblebrook Hotel Trust · Stock research
Last analysed ·
Current thesis
The 2026-07-29 binary resolved bullish — Q2 RevPAR +6.5%, AFFO $0.68, FY guide raised to $345–353M EBITDAre — and the stock still has not made a new high, closing 2026-08-14 at $18.25, 7.6% under the $19.75 high with RSI 35.3. Q3 guidance of +1%–3% RevPAR quarters the growth rate, and the completed sell-side file carries a $16.98 average target, below the market.
Kill line
A weekly close below $16 surrenders the June 2026 breakout shelf and returns PEB to its $13–15 base; secondary condition: Q3 same-property RevPAR at or under the low end of the +1%–3% guide, or a trim to the $345–353M FY adjusted EBITDAre range, at the ~2026-10-27 print.
Pick status
Open commitment scored if the kill line above fires How this is scored →Latest analysis and events for PEB —
As of 16 August 2026, the latest FrontierPicks analysis for Pebblebrook Hotel Trust (PEB): The 2026-07-29 binary resolved bullish — Q2 RevPAR +6.5%, AFFO $0.68, FY guide raised to $345–353M EBITDAre — and the stock still has not made a new high, closing 2026-08-14 at $18.25, 7.6% under the $19.75 high with RSI 35.3. Q3 guidance of +1%–3% RevPAR quarters the growth rate, and the completed sell-side file carries a $16.98 average target, below the market.
Kill line: A weekly close below $16 surrenders the June 2026 breakout shelf and returns PEB to its $13–15 base; secondary condition: Q3 same-property RevPAR at or under the low end of the +1%–3% guide, or a trim to the $345–353M FY adjusted EBITDAre range, at the ~2026-10-27 print.
Current Thesis
The event the June–July leg was pointing at has come and gone. Pebblebrook reported Q2 on 2026-07-29: same-property RevPAR +6.5% on ADR of $326.60 (+4.7%) and occupancy of 79.4% (+1.7pp), Same-Property Hotel EBITDA of $123.3M — $6.6M above the top of management's own outlook and +7.1% year-on-year — and adjusted FFO of $0.68, $0.06 above the high end. Full-year guidance was raised to $345.0–353.0M adjusted EBITDAre, $1.69–1.76 AFFO per share, and +4.1% to +5.3% same-property total RevPAR. On the numbers the print cleared.
The price has not followed. The 2026-08-14 close was $18.25, 7.6% under the 52-week high of $19.75 that was set before the beat, with RSI(14) at 35.3 despite a 29.9% three-month gain. Two dated things sit behind that fade. The Q3 outlook is +1% to +3% same-property RevPAR and $0.48–0.52 AFFO — roughly a quarter of the growth rate just delivered — because Washington D.C. (RevPAR -9.9%, government-related demand) and the four urban San Diego hotels (-9.1%, weaker convention calendar) are eating into what resorts (+12.0%) and San Francisco (+16.0% RevPAR, +24.6% hotel EBITDA) produce. And the sell-side file is now closed: Cantor Fitzgerald held Neutral and marked to $19 on 2026-08-11, Ladenburg moved to $21 Neutral on 2026-08-31's predecessor date 2026-07-31, and an aggregator tally published 2026-08-05 counted fifteen covering brokerages at a modal Hold with an average 12-month target of $16.98 — under the market.
The narrative is saturated. What dates it: full sell-side coverage with a Hold consensus (2026-08-05), a beat-and-raise on 2026-07-29 that produced no new high, and a fifteen-session drift to 7.6% below that high with RSI in the mid-30s (2026-08-14). Fundamental momentum is intact; incremental buyers are not showing up for it.
Bullish and bearish views on Pebblebrook Hotel Trust
The model's bull view on Pebblebrook Hotel Trust (PEB), in brief: Q2 2026 (reported 2026-07-29) beat on every headline line: same-property RevPAR +6.5%, Same-Property Hotel EBITDA $123.3M ($6.6M above the high end of guidance), AFFO $0.68 ($0.06 above the high end). The bear view: The growth rate quarters next quarter: Q3 guidance of +1% to +3% same-property RevPAR against +6.5% delivered in Q2, with adjusted EBITDAre guided to $92.5–96.5M (2026-07-29 release). Both cases follow in full.
Bull Case
- Q2 2026 (reported 2026-07-29) beat on every headline line: same-property RevPAR +6.5%, Same-Property Hotel EBITDA $123.3M ($6.6M above the high end of guidance), AFFO $0.68 ($0.06 above the high end).
- Guidance raised, not merely reiterated: FY 2026 adjusted EBITDAre to $345.0–353.0M and AFFO/share to $1.69–1.76 at the 2026-07-29 release — the second consecutive raise after the 2026-04-28 Q1 lift.
- The urban West Coast inflection is showing in the segment data: San Francisco RevPAR +16.0% and hotel EBITDA +24.6% in Q2 — the specific recovery the mid-teens tape refused to credit through 2025.
- Resorts are not rolling over yet: Q2 resort RevPAR +12.0%, total RevPAR +10.9%, hotel EBITDA +18.5%.
- Capital allocation is shrinking the equity and the preferred stack: H1 2026 repurchases of 0.9M common shares at an average of $13.62 and 1.5M preferred shares for $28.6M at a 23% discount to liquidation preference; the Chamberlain West Hollywood Hotel was sold for $43.5M.
- Liquidity is not the constraint: $270.4M cash and $641M of revolver availability at 2026-06-30, with a 4.1% weighted-average interest rate on debt.
- One target sits above the market: Ladenburg Thalmann raised to $21 (Neutral) on 2026-07-31.
Bear Case
- The growth rate quarters next quarter: Q3 guidance of +1% to +3% same-property RevPAR against +6.5% delivered in Q2, with adjusted EBITDAre guided to $92.5–96.5M (2026-07-29 release).
- Two markets are outright shrinking: D.C. RevPAR -9.9% on government-related demand and urban San Diego -9.1% on the convention calendar in Q2 — both are structural-calendar problems, not weather.
- The beat did not clear the high: the 52-week high of $19.75 predates the 2026-07-29 print, and the 2026-08-14 close of $18.25 is 7.6% below it. A raise that fails to make a new high is the market pricing the raise as already known.
- Consensus targets sit under the market: an average 12-month target of $16.98 across fifteen brokerages as of 2026-08-05, with the modal rating Hold and sell ratings present; Cantor's 2026-08-11 raise to $19 kept a Neutral rating.
- Whether it continues near current prices is the open question at the next filing.
- The dividend gives no support: the declared common dividend is $0.01 per share per quarter — a REIT wrapper with essentially no yield to attract income buyers.
- Leverage is still 5.3x: net debt to trailing-twelve-month EBITDA at 5.3x as of the Q2 print means the equity is geared to both RevPAR and the refinancing path.
Setup & Price Structure
- Reference close 2026-08-14: $18.25. 52-week high $19.75 (-7.6%). Three-month return +29.9%. RSI(14) 35.3.
- The divergence is the structural fact worth naming: price still 29.9% above where it was three months ago while the 14-day RSI sits in the mid-30s. Momentum has drained out of the leg without the leg's structure breaking.
- The level that defines the trade is the June breakout shelf near $16, the ceiling of the multi-year $13–15 base the stock escaped in June 2026. Above it, this is a consolidation inside a re-rate. Below it, the re-rate is retraced.
- Crowding/positioning observables (stated, not judged): sell-side coverage completed in a tight cluster between 2026-07-17 and 2026-08-11 (Morgan Stanley UW $13, Barclays UW $15, Citi Neutral $20, Wells Fargo EW $19, Ladenburg Neutral $21, Cantor Neutral $19); the aggregate target sits below spot (2026-08-05); no earnings date falls inside the next 30 days; the company was a net repurchaser of its own common and preferred in H1 2026 rather than an issuer into strength.
- No base has formed since the post-print fade. There is no dated event inside 30 days that resolves the deceleration question, which is what makes fresh exposure here a low-conviction proposition rather than a setup.
Catalyst Calendar (next 30 days)
- ~2026-09-15 (est.) — Q3 2026 common dividend declaration. The comparable announcement was filed 2025-09-15; the run-rate is $0.01 per share. Immaterial to cash flow; a change would be a signal about management's capital-allocation preference between dividend, buyback and deleveraging.
- ~2026-09-30 (est., per aggregator dividend schedules) — ex-dividend date for the $0.01 quarterly common dividend, payable ~2026-10-15.
- ~2026-10-27 (est.) — Q3 2026 earnings. Outside the 30-day window, and the only event that tests the +1%–3% RevPAR guide and the raised FY $345–353M EBITDAre.
- Nothing inside the window resolves the thesis. The 30 days ahead are a price-structure question, not an information question.
What Would Change Our Mind
The June breakout shelf is the whole leg. Losing it returns the shares to the $13–15 range they occupied for years, and the gradeable version of that is a weekly close below $16. That would say the 2026-07-29 beat-and-raise bought no durable re-rating and the discount-to-NAV closure has reversed.
Second condition: Q3 same-property RevPAR printing at or below the low end of the +1%–3% guide at the ~2026-10-27 report, or any trim to the $345–353M FY adjusted EBITDAre range, would confirm the deceleration is demand-driven rather than a D.C./San Diego calendar artifact.
What would argue the other way: a weekly close above $19.75 on expanding volume reopens the leg; D.C. RevPAR turning positive year-on-year in Q3, resort RevPAR holding double-digit growth, and continued common repurchases disclosed at prices near the current market would all argue the Q3 guide was conservative rather than a peak.
Correlation Notes
- Rate path. 5.3x net debt/TTM EBITDA at a 4.1% weighted-average interest rate makes the equity higher-beta to the long end than lower-levered lodging REITs. Moves in the 10-year tend to hit PEB harder than the group.
- Lodging REIT complex. Trades with DRH, RLJ, XHR and SHO on RevPAR datapoints and with the broader REIT tape on rates; a group RevPAR miss from any large operator reads through directly.
- Government travel. The -9.9% D.C. RevPAR line ties the name to federal travel budgets in a way that resort-heavy peers do not share.
- Group/convention calendars. San Diego's -9.1% is calendar-driven; convention bookings are known 12–18 months ahead, so the read-through is scheduled rather than cyclical.
- Bay Area business travel. The +16.0% San Francisco RevPAR line is a second-order read on the AI-capex boom converting into room nights and conference demand — a link that fails if Bay Area hiring and event volume stall.
- High-income discretionary spend. Resort RevPAR +12.0% is levered to the top-quintile consumer; an equity drawdown transmits to that line with a lag.
Notes
- Common dividend runs at $0.01/share per quarter — the REIT wrapper offers effectively no yield support for the equity.
- Preferred stack sits ahead of the common; 1.5M preferred shares were repurchased in H1 2026 at a 23% discount to liquidation preference.
- Chamberlain West Hollywood was sold for $43.5M in H1 2026, so portfolio hotel/room counts published before mid-2026 are stale.
- Net debt/TTM EBITDA was 5.3x at the Q2 2026 print — higher-beta to the rate path than lower-levered lodging peers.
- Reporting cadence puts the next earnings event in late October; an earnings blackout applies in the trading days ahead of it.
Related · shared themes
ALGT
Allegiant Travel Company
Allegiant closed the $1.5B Sun Country acquisition (2026-05-13) to become the largest US leisure airline just as fuel flipped to a tailwind and the whole sell-side re-rated it to $142–$160; the move has more than doubled off the low, and the first partly-combined Q2 print on 2026-08-04 is the binary.
CCS
Century Communities, Inc.
Post-Q2 re-rate is consolidating rather than extending: the 2026-08-21 close of $69.78 is 5.8% under the $74.04 high with RSI 52.4. August HMI ticked up to 35 and Freddie Mac fell a second week to 6.65%, but July single-family starts dropped 9.9% to 808k. No company disclosure until Q3 in late October — the next 30 days are macro-only.
HNI
HNI Corporation
Steelcase synergy capture confirmed on the 2026-07-30 Q2 print — non-GAAP EPS $1.27 vs $1.04 consensus, FY2026 guide lifted to 20–25% growth from mid-teens — and the legacy-furniture value trap re-rated from $39.70 (2026-07-15) to $48.86 (2026-08-14). Narrative accelerating; tape extended at RSI 75.6 with no company catalyst until the ~late-October Q3 print.
LIND
Lindblad Expeditions Holdings Inc.
Post-catalyst drift, not a broken story: the 2026-08-03 beat (revenue $199.2M vs $185.85M est, occupancy 91%) carried price to a $34.48 high, and with nothing scheduled before the ~2026-11-03 Q3 print it has bled to $31.09 with RSI 36.1. Now purely an occupancy/pricing execution leg against a fuel-capped $130-140M EBITDA guide.